Lymphadenectomy in NSCLC With and Without Adjuvant Therapy
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to NSCLC
Related studies linked through entity extraction aliases.
Detecting Lung Cancer Based on Exhaled Breath
- Status
- COMPLETED
- Phase
- N/A
A Phase Ib Study With Pegylated Recombinant Human Endostatin in Advanced / Metastatic NSCLC or Other Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Correlation Between Specific Gene Mutationand Local Immune Microenvironment and Immunotherapy Efficacy in NSCLC
- Status
- UNKNOWN
- Phase
- N/A
Study of Poziotinib in Japanese Patients With NSCLC
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Durvalumab(MEDI4736) After chemoRadioTherapy(DART) for NSCLC-a Translational and Biomarker Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Drug-drug Interaction Study of Gefitinb on Apatinib in NSCLC Patients
- Status
- UNKNOWN
- Phase
- PHASE1
Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Adjuvant Treatment With Cisplatin-based Chemotherapy Plus Concomitant Atezolizumab in Patients With Stage I (Tumors ≥ 4cm), IIA, IIB, and Select Stage III [Any T1-3 N1-2 and T4N0-2] Resected Non-small Cell Lung Cancer (NSCLC) and the Clearance of Circulating Tumor DNA (ctDNA)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Analysis of Gut Microbiota in Patients With Brain Metastasis of Non-small Cell Lung Cancer Treated by Pembrolizumab Combined With Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Advancing Brigatinib Properties in ALK+ NSCLC Patients by Deep Phenotyping
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Anlotinib In Combination With PD-1/L1 Inhibitor As Sequential Therapy of Thoracic Radiotherapy After Induction Chemotherapy For Extensive-Stage Small Cell Lung Cancer:A Single Arm Study
- Status
- UNKNOWN
- Phase
- PHASE2
Lorlatinib Combinations in Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Pathological and Nuclear Medicine Factors for Prognosis in Lung Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Sintilimab Versus Pembrolizumab for Advanced-stage Non-Small-Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Multimodality Treatment in Stage III Non-small Cell Lung Cancer (NSCLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Utility of Liquid Biopsy in Brigatinib ALK+ Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of TY-9591 in Advanced Non-small Cell Lung Cancer(NSCLC) Patients With EGFR Positive Mutation
- Status
- COMPLETED
- Phase
- PHASE1